Ziprasidone (Page 9 of 9)

PRINCIPAL DISPLAY PANEL — 20 mg Capsule Bottle Label — 59762-2001

NDC 59762-2001-1
60 Capsules

GREENSTONE ® BRAND

ziprasidone HCl

20 mg*

Rx only

PRINCIPAL DISPLAY PANEL -- 20 mg Capsule Bottle Label -- 59762-2001
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 40 mg Capsule Bottle Label — 59762-2002

NDC 59762-2002-1
60 Capsules

GREENSTONE ® BRAND

ziprasidone HCl

40 mg*

Rx only

PRINCIPAL DISPLAY PANEL -- 40 mg Capsule Bottle Label -- 59762-2002
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 60 mg Capsule Bottle Label — 59762-2003

NDC 59762-2003-1
60 Capsules

GREENSTONE ® BRAND

ziprasidone HCl

60 mg*

Rx only

PRINCIPAL DISPLAY PANEL -- 60 mg Capsule Bottle Label -- 59762-2003
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 80 mg Capsule Bottle Label — 59762-2004

NDC 59762-2004-1
60 Capsules

GREENSTONE ® BRAND

ziprasidone HCl

80 mg*

Rx only

PRINCIPAL DISPLAY PANEL -- 80 mg Capsule Bottle Label -- 59762-2004
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 20 mg Capsule Bottle Label — 59762-1006

NDC 59762-1006-160 Capsules

GREENSTONE® BRAND

ziprasidone

20 mg*

Rx only

PRINCIPAL DISPLAY PANEL -- 20 mg Capsule Bottle Label -- 59762-1006
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 40 mg Capsule Bottle Label — 59762-1008

NDC 59762-1008-160 Capsules

GREENSTONE® BRAND

ziprasidone

40 mg*

Rx only

PRINCIPAL DISPLAY PANEL -- 40 mg Capsule Bottle Label -- 59762-1008
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 60 mg Capsule Bottle Label — 59762-1012

NDC 59762-1012-160 Capsules

GREENSTONE® BRAND

ziprasidone

60 mg*

Rx only

PRINCIPAL DISPLAY PANEL -- 60 mg Capsule Bottle Label -- 59762-1012
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 80 mg Capsule Bottle Label — 59762-1014

NDC 59762-1014-160 Capsules

GREENSTONE® BRAND

ziprasidone

80 mg*

Rx only

PRINCIPAL DISPLAY PANEL -- 80 mg Capsule Bottle Label -- 59762-1014
(click image for full-size original)
ZIPRASIDONE ziprasidone hydrochloride capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59762-2001
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE) ZIPRASIDONE 20 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
Product Characteristics
Color BLUE, WHITE Score no score
Shape CAPSULE Size 14mm
Flavor Imprint Code G;2001
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59762-2001-1 60 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA authorized generic NDA020825 02/05/2001 08/31/2022
ZIPRASIDONE ziprasidone hydrochloride capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59762-2002
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE) ZIPRASIDONE 40 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
Product Characteristics
Color BLUE Score no score
Shape CAPSULE Size 14mm
Flavor Imprint Code G;2002
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59762-2002-1 60 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA authorized generic NDA020825 02/05/2001 05/31/2024
ZIPRASIDONE ziprasidone hydrochloride capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59762-2003
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE) ZIPRASIDONE 60 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
Product Characteristics
Color WHITE Score no score
Shape CAPSULE Size 16mm
Flavor Imprint Code G;2003
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59762-2003-1 60 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA authorized generic NDA020825 02/05/2001 05/31/2024
ZIPRASIDONE ziprasidone hydrochloride capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59762-2004
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE) ZIPRASIDONE 80 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
Product Characteristics
Color BLUE, WHITE Score no score
Shape CAPSULE Size 18mm
Flavor Imprint Code G;2004
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59762-2004-1 60 CAPSULE in 1 BOTTLE None
2 NDC:59762-2004-2 500 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA authorized generic NDA020825 02/05/2001 04/30/2024
ZIPRASIDONE ziprasidone capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59762-1006
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE) ZIPRASIDONE 20 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
Product Characteristics
Color BLUE, WHITE Score no score
Shape CAPSULE Size 14mm
Flavor Imprint Code G;2001
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59762-1006-1 60 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA authorized generic NDA020825 11/03/2021 01/31/2026
ZIPRASIDONE ziprasidone capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59762-1008
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE) ZIPRASIDONE 40 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
Product Characteristics
Color BLUE Score no score
Shape CAPSULE Size 14mm
Flavor Imprint Code G;2002
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59762-1008-1 60 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA authorized generic NDA020825 05/31/2023 09/30/2025
ZIPRASIDONE ziprasidone capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59762-1012
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE) ZIPRASIDONE 60 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
Product Characteristics
Color WHITE Score no score
Shape CAPSULE Size 16mm
Flavor Imprint Code G;2003
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59762-1012-1 60 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA authorized generic NDA020825 05/31/2023 09/30/2025
ZIPRASIDONE ziprasidone capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59762-1014
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE) ZIPRASIDONE 80 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
Product Characteristics
Color BLUE, WHITE Score no score
Shape CAPSULE Size 18mm
Flavor Imprint Code G;2004
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59762-1014-1 60 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA authorized generic NDA020825 05/31/2023 09/30/2025
Labeler — Greenstone LLC (825560733)

Revised: 03/2022 Greenstone LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.